Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 97,984 | 98,521 | 54,455 | 113,009 | 119,800 |
| Marketable Securities | 70,917 | 48,594 | 70,288 | 58,742 | 71,744 |
| Receivables | 67,608 | 65,104 | 106,484 | 94,163 | 77,588 |
| Inventories | 22,906 | 30,388 | 33,676 | 31,553 | 28,644 |
| TOTAL | $283,374 | $263,557 | $290,637 | $316,567 | $340,839 |
| Non-Current Assets | |||||
| PPE Net | 2,415 | 3,031 | 3,312 | 4,116 | 7,912 |
| Intangibles | 424,486 | 426,459 | 436,296 | 446,133 | 610,090 |
| Other Non-Current Assets | 24,081 | 22,502 | 23,330 | 24,411 | 7,767 |
| TOTAL | $450,982 | $451,992 | $462,938 | $474,660 | $625,769 |
| Total Assets | $734,356 | $715,549 | $753,575 | $791,227 | $966,608 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,742 | 12,944 | 16,520 | 27,021 | 26,554 |
| Accrued Expenses | 146,597 | 144,567 | 167,661 | 183,382 | 172,285 |
| Other current liabilities | N/A | N/A | N/A | 17 | 113 |
| TOTAL | $161,977 | $160,999 | $188,246 | $214,497 | $204,074 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,477 | N/A | N/A | N/A | 1,128 |
| Other Non-Current Liabilities | 308,695 | 305,228 | 301,591 | 296,914 | 276,735 |
| TOTAL | $316,357 | $305,228 | $301,591 | $296,914 | $281,906 |
| Total Liabilities | $478,334 | $466,227 | $489,837 | $511,411 | $485,980 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,725 | 34,480 | 34,273 | 34,266 | 33,916 |
| Common Shares | 345 | 344 | 342 | 339 | 339 |
| Retained earnings | -1,046,667 | -1,051,153 | -1,033,389 | -1,015,201 | -808,970 |
| Other shareholders' equity | -3,068 | -2,964 | -3,787 | -3,239 | -3,199 |
| TOTAL | $256,022 | $249,322 | $263,738 | $279,816 | $480,628 |
| Total Liabilities And Equity | $734,356 | $715,549 | $753,575 | $791,227 | $966,608 |